checkAd

     310  0 Kommentare Two Day Veterinary Drug Approval Process and FDA Regulatory Oversight Seminar - Kansas City, MO, United States - May 17th-18th, 2018

    DUBLIN, Jan. 17, 2018 /PRNewswire/ --

    The "The Veterinary Drug Approval Process and FDA Regulatory Oversight: 2-day In-Person Seminar" conference has been added to ResearchAndMarkets.com's offering.

    Research and Markets Logo

    The U.S. Food and Drug Administration's Center for Veterinary Medicine or CVM is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies.

    For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.

    This seminar on veterinary medicine regulations will provide attendees with an understanding of FDA's veterinary drug approval process.

    This two day interactive course will cover:

    • Premarket approval process
    • Various sections of a New Animal Drug Application
    • Strategies for navigating the FDA approval process and for expending product approval
    • The nature of shared jurisdiction over veterinary products in certain cases

    Learning Objectives:

    • Understand how the U.S. Food and Drug Administration regulates veterinary drug product.
    • Understand how FDA's Center for Veterinary Medicine is organized.
    • Discuss the process by which veterinary drug products are reviewed and approved.
    • Learn how to open an INAD File and request fee waivers.
    • Obtain a working knowledge of various sections included within an NADA.
    • Develop a deep understanding of what is needed to substantiate product characterization, target safety and effectiveness.
    • Analyze FDA's rules governing chemistry, manufacturing and controls or CMC.
    • Understand the various components of an animal field study to support product approval.
    • Discuss the difference between FDA's various user fees and fee waivers.
    • Identify the elements of an FDA compliant label.
    • Develop a corporate compliance strategy covering labeling, marketing and advertising.
    • Problem solving methods to mitigate regulatory enforcement risks.
    • Explain how jurisdiction is split between various Federal agencies in a certain cases.
    • Learn how animal feed, veterinary devices, OTC drug products and nutritional supplement are regulated in the U.S.

    Who Should Attend:

    • Personnel new to the Animal Health Industry
    • CRO professionals
    • Entrepreneurs looking to add value to their products
    • Regulatory professionals
    • Compliance professionals
    • U.S. Agents of Foreign Corporations
    • Process owners
    • Document control specialists
    • Record retention specialists
    • Legal Professionals
    • Financial Advisors and Institutional Investors
    • Consultants, Inspectors and cGxP Experts

    For more information about this conference visit https://www.researchandmarkets.com/research/mqs3tv/two_day?w=5

    Media Contact:


    Research and Markets
    Laura Wood, Senior Manager
    press@researchandmarkets.com  

    For E.S.T Office Hours Call +1-917-300-0470
    For U.S./CAN Toll Free Call +1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716

     





    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Two Day Veterinary Drug Approval Process and FDA Regulatory Oversight Seminar - Kansas City, MO, United States - May 17th-18th, 2018 DUBLIN, Jan. 17, 2018 /PRNewswire/ - The "The Veterinary Drug Approval Process and FDA Regulatory Oversight: 2-day In-Person Seminar" conference has been added to ResearchAndMarkets.com's offering. The U.S. Food and Drug Administration's Center for …